Carb cycling: What is it, and does it work?
Salmonella, E. coli, Cyclospora, and other germs that cause food poisoning: What you need to know
Understanding orthorexia: Have your healthy eating goals gone too far?
Melatonin or magnesium: Can either supplement help you sleep?
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Naturally gluten-free foods
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks
David M. Nathan, MD
Editorial Advisory Board Member, Harvard Health Publishing
Dr. David M. Nathan is a professor of medicine at Harvard Medical School, and is director of the diabetes center and the clinical research center at Massachusetts General Hospital. An internationally acclaimed expert on diabetes, he has led some of the most important studies in its treatment and prevention, including the Diabetes Control and Complications Trial; Epidemiology of Diabetes Interventions and Complications Study; Diabetes Prevention Program: and the GRADE study. He was awarded the Outstanding Clinician Award in 2002 and the Outstanding Achievement in Clinical Diabetes Research Award in 2015, both from the American Diabetes Association, and the Distinguished Scientist Award from the National Institute of Diabetes Digestive and Kidney Disease/NIH in 2010.
Carb cycling: What is it, and does it work?
Salmonella, E. coli, Cyclospora, and other germs that cause food poisoning: What you need to know
Understanding orthorexia: Have your healthy eating goals gone too far?
Melatonin or magnesium: Can either supplement help you sleep?
Harvard study: Healthier fats linked to longer life after prostate cancer diagnosis
Naturally gluten-free foods
Shingrix shingles vaccine linked with lower heart disease risks
Estrogen-only hormone therapy tied to lower dementia risk
Should you have a hysterectomy?
Stair climbing may significantly lower cardiovascular risks